Abstract: The present invention is concerned with novel compositions and vaccines useful for prophylactic an/or therapeutic treatment of mucosal infections, and in particular it is concerned with oral vaccines and with methods of enhancing mucosal resistance to infection or for treating established infections, of the respiratory tract.
Type:
Grant
Filed:
May 21, 2001
Date of Patent:
January 28, 2014
Assignee:
Hunter Immunology Limited
Inventors:
Robert Llewellyn Clancy, Gerald Pang, Margaret Lorraine Dunkley
Abstract: The present invention relates to compositions of rosmarinic acid or its derivatives and to the use of a hydrolytic enzyme or of microorganism containing or producing hydrolytic enzymes in these compositions. The invention also pertains to methods for improving the biological effects of the rosemary extracts and for administering such compositions to a human or animal subject for improving the skin, coat, hair or health of the subject.
Type:
Application
Filed:
September 18, 2013
Publication date:
January 23, 2014
Applicants:
L'ORÉAL, Nestec S.A.
Inventors:
Vanessa CRESPY, Isabelle CASTIEL, Rachid BEL-RHLID, Nicolas PAGE, Thomas RAAB
Abstract: The present invention relates to bacterial formulation in vegetable fiber materials, which can be employed by incorporation into soils and by treating seeds, as well as in nutrient in hydroponic systems, for the promotion of plant growth and/or the biologic control of diseases. Preferably, the formulation of the present invention employs coconut fiber. An advantage of the present invention is the possible replacement of turf and other organic or inorganic materials employed in the formulation of inoculants and of agents for the biologic control of bacteria and fungi by coconut fiber.
Type:
Application
Filed:
October 27, 2011
Publication date:
January 23, 2014
Applicant:
EMPRESA BRASILEIRA DE PESQUISA AGROPECUARIA- EMBRAPA
Abstract: A specific naturally occurring or genetically modified bacterial strain can be introduced into the hair follicle of patients suffering from androgenetic alopecia as to reduce the bioavailable extracellular testosterone and hence reduce the effect of androgens on the hair follicle.
Abstract: The invention relates to porous films comprising crosslinked electrospun hydrogel fibers. Viable microbes are encapsulated within the crosslinked electrospun hydrogel fibers. The crosslinked electrospun hydrogel fibers are water insoluble and permeable. The invention also relates to methods of making and using such porous films.
Type:
Application
Filed:
December 21, 2012
Publication date:
January 16, 2014
Inventors:
Devicharan Chidambaram, Ying Liu, Miriam H. Rafailovich
Abstract: The present invention relates to a method for the preparation of a fermented milk product comprising Bifidobacteria in combination with lactic acid bacteria of the species Lactococcus lactis, Sterptococcus thermophilus, and/or Lactobacillus bulgaricus. The problem to be solved is to provide a method to improve growth of Bifidobacteria population in milk during the fermentation process for making fermented milk products (e.g. a yogurt) in order to obtain a high cell count of Bifidobacteria in the final product.
Type:
Grant
Filed:
August 28, 2009
Date of Patent:
January 14, 2014
Assignee:
CHR-Hansen A/S
Inventors:
Ditte Marie Folkenberg, Cecile Seimandi
Abstract: Bacterial compositions effective for inhibiting fungal diseases of potatoes and/or potato sprouting are produced by co-culture of two or more of Pseudomonas fluorescens (NRRL B-21133), Pseudomonas fluorescens biovar (NRRL B-21053), Pseudomonas fluorescens (NRRL B-21102) and Enterobacter cloacae (NRRL B-21050). Compositions produced by co-culture of these bacteria together in the same culture medium are significantly more effective for inhibiting fungi-induced diseases of potatoes and/or inhibiting sprouting of potatoes, than blends or mixtures of the same bacteria cultured separately.
Type:
Grant
Filed:
August 29, 2012
Date of Patent:
January 14, 2014
Assignee:
The United States of America as represented by the Secretary of Agriculture
Inventors:
Patricia J. Slininger, David A. Schisler
Abstract: The present invention relates to bacteria cultures and composition comprising one or more cultures of the invention. The invention also relates to methods of washing or cleaning laundry or fabrics and surfaces as well as degrading waste material using a bacteria culture of the invention.
Abstract: This disclosure relates to enhancing growth and/or activity of lactobacilli using a prebiotic formulation which includes iso-malto oligosaccharides and ?-galactosidase; and to enhancing growth and/or activity of bifidobacteria using a prebiotic formulation which includes iso-malto oligosaccharides and ?-glucanase. Other combinations of fibers and enzymes are described below which also stimulate growth and activity of lactobacilli or bifidobacteria. These combinations of enzymes and prebiotics can be taken separately or added to foods, including desserts.
Abstract: Six bacterial strains: Bacillus simplex strain 03WN13, Bacillus simplex strain 03WN23, Bacillus simplex strain 03WN25, Pseudomonas koreensis strain 10IL21, Pantoea agglomerans strain 10IL31, and Pseudomonas lini strain 13IL01, are superior antagonists of Phytophthora erythroseptica Pethybr., the causative agent of pink rot on potatoes. These bacterial strains are effective for suppression and control of pink rot on potatoes.
Type:
Grant
Filed:
September 24, 2010
Date of Patent:
January 7, 2014
Assignee:
The United States of America, as represented by the Secretary of Agriculture
Inventors:
David A. Schisler, Patricia J. Slininger, Tugba Adiyaman
Abstract: The present invention uses co-expression of protease inhibitors and protease sensitive therapeutic agents that results in their localized production within the target tissue and inactivation outside of the target tissue, thereby increasing therapeutic activity and reducing the systemic toxicity. Inactivation is also accomplished by engineering protease degradation sites within the therapeutic construct for proteases, preferably those that are under-expressed within the target tissue yet present in non-target tissues within the body, resulting in therapeutic activity within the target tissue and inactivation outside of the target tissue. Novel chimeric proteins secreted by bacteria are also described. The chimeric proteins include chimeric toxins targeted to neoplastic cells and cells of the immune system. Novel combination therapies of these protease inhibitor:chimeric toxin-expressing bacteria together with small-molecule and biologic agents are also described.
Abstract: Exemplary embodiments disclosed herein include a microorganism that produces, secretes and injects recombinant antibodies into eukaryote cells said the described microorganisms can be used to prepare pharmaceutical compositions for the treatment of human or veterinary diseases.
Type:
Grant
Filed:
March 12, 2008
Date of Patent:
January 7, 2014
Assignee:
Consejo Superior de Investigaciones Cientificas
Inventors:
Luis Angel Fernandez Herrero, Ana Blanco Toribio
Abstract: A method of enhancing the antimicrobial properties of a bacterial strain, comprising cultivation of the bacterial strain in a medium comprising water, at least one component chosen from bee pollen, pollen, and bee bread, and optionally honey and/or nectar is described. The bacterial strain has the ability to be viable for at least 8 days in a 65% by weight sugar solution, preferably at least 8 days in a 70% by weight sugar solution.
Abstract: Dairy compositions are provided having a high pH, of about 4.8 to about 6.2, comprising desirable probiotic cultures as well as an anti-microbial system for inhibiting undesirable pathogenic and/or spoilage microbial growth without significantly reducing the beneficial effect of the probiotic cultures.
Type:
Grant
Filed:
December 10, 2012
Date of Patent:
December 31, 2013
Assignee:
Kraft Foods Group Brands LLC
Inventors:
Gary Francis Smith, Alice Shen Cha, Zuoxing Zheng, Michael Gerard Roman, Benjamin Emanuel Dias
Abstract: Bacterial strains are provided that can be isolated from the microflora of lowbush blueberry (Vaccinium angustifolium), and that are capable of increasing the antioxidant content of their growth medium. The bacteria can be used, for example, to increase the antioxidant content of various foodstuffs, as probiotics or as additives to animal feed. Antioxidant-enriched compositions produced by fermentation processes utilizing the bacteria are also provided. The antioxidant-enriched compositions can be used in the preparation of cosmetics and nutritional supplements. The antioxidant-enriched compositions also have therapeutic applications.
Abstract: This document provides methods and materials related to Prevotella histicola preparations. For example, Prevotella histicola preparations in the form of an oral medicament or dietary supplement (e.g., a pill, tablet, capsule) are provided. In addition, methods and materials for using a Prevotella histicola preparation provided herein as an anti-inflammatory agent are provided.
Type:
Grant
Filed:
October 27, 2010
Date of Patent:
December 31, 2013
Assignee:
Mayo Foundation for Medical Education and Research
Inventors:
Joseph A. Murray, Eric V. Marietta, Susan H. Barton, Veena Taneja, Ashutosh Mangalam
Abstract: The present invention relates generally to the field of nutrition, more particularly to the use of probiotics in nutrition. In particular the present invention relates to the use of a probiotic or of a mixture of probiotics in the manufacture of a nutritional composition or a medicament to act the colon in a pre- or post surgical environment.
Abstract: Disclosed are compounds of Formula 1, wherein X is O or S; Y is O or S; and R1, R2, R3 and R4 are as defined in the disclosure. Also disclosed are compositions containing the compounds of Formula 1 and methods for controlling an invertebrate pest comprising contacting the invertebrate pest or its environment with a biologically effective amount of a compound or a composition of the invention.
Type:
Application
Filed:
August 15, 2013
Publication date:
December 19, 2013
Applicant:
E I DU PONT DE NEMOURS AND COMPANY
Inventors:
CALEB WILLIAM HOLYOKE, JR., WENWING ZHANG
Abstract: The present invention relates to methods for a ong-term and sustained release of flavonoids, in particular rhamnose-containing flavonoids, and for prolonging the uptake of said flavonoids in the gastro-intestinal tract. It further relates to compositions comprising said flavonoid and ?-rhamnosidase. It also encompasses compositions comprising hesperidin and hesperetin-7-gluoside.
Type:
Application
Filed:
March 15, 2013
Publication date:
December 19, 2013
Inventors:
Myriam Richelle, Gary . Williamson, Ivana Jankovic, Maarit Rein
Abstract: Plant propagation material expressing soybean cyst nematode resistance can be treated with a nematode-antagonistic biocontrol agent. Use of the nematode-antagonistic biocontrol agent can reduce the rate at which soybean cyst nematode (SCN) pests acquire tolerances to pesticidal activity of soybean plants expressing SCN resistance and pesticides, and can also increase yield and pesticidal activity.
Type:
Application
Filed:
April 13, 2012
Publication date:
December 19, 2013
Applicant:
Syngenta Participations AG
Inventors:
Palle Pedersen, Clifford George Watrin, Michael Oostendorp, Andre Luiz Freitas de Oliveira
Abstract: The present invention is directed to pharmaceutical compositions and methods of treatment that relate to the inhibition, resolution and/or prevention of an array of the manifestations of metabolic syndromes, including Type 2 diabetes, hyperlipidemia, weight gain, obesity, insulin resistance, hypertension, atherosclerosis, fatty liver diseases and certain chronic inflammatory states that lead to these manifestations, among others. In additional aspects, the present invention relates to compositions and methods which may be used to treat, inhibit or reduce the likelihood of hepatitis viral infections, including Hepatitis B and Hepatitis C viral infections, as well as the secondary disease states and/or conditions which are often associated with such viral infections, including hepatic steatosis (steatohepatitis), cirrhosis, fatty liver and hepatocellular cancer, among other disease states or conditions.
Abstract: The present invention relates to a mutated Francisella bacterium, wherein the ggt gene is silenced or deleted; pharmaceutical compositions comprising the same, in particular, vaccine compositions, and use of the bacterium and compositions for treatment and/or prophylaxis, and in particular, the treatment or prophylaxis of tularemia.
Type:
Grant
Filed:
April 14, 2010
Date of Patent:
December 17, 2013
Assignee:
The Secretary of State for Defence
Inventors:
Helen Le Butt, Phillip Matthew Ireland, Petra Claire Farquar Oyston
Abstract: This invention relates to using bacterial metabolites to suppress phytopathogens, more particularly this invention relates to bacterial metabolites applied to Carya illinoensis and Prunus persica as a fungicide to suppress and inhibit Glomerella cingulata, Phomopsis sp., Phytophthora cactorum, Fusicladosporium effusum, and Monilinia fructicola.
Type:
Grant
Filed:
March 22, 2007
Date of Patent:
December 17, 2013
Assignee:
The United States of America, as represented by the Secretary of Agriculture
Inventors:
David I. Shapiro-Ilan, Charles C. Reilly
Abstract: A feed additive composition comprising a direct fed microbial in combination with a protease, and a phytase, and a method for improving the performance of a subject or for improving digestibility of a raw material in a feed (e.g. nutrient digestibility, such as amino acid digestibility), or for improving nitrogen retention, or for improving the subject's resistance to necrotic enteritis or for improving feed conversion ratio (FCR) or for improving weight gain in a subject or for improving feed efficiency in a subject or for modulating (e.g. improving) the immune response of the subject or for promoting the growth of beneficial bacteria in the gastrointestinal tract of a subject, which method comprising administering to a subject a direct fed microbial in combination with a protease and a phytase.
Abstract: A feed additive composition comprising a direct fed microbial (DFM) in combination with a phytase derivable from Citrobacter spp. and a method for improving the performance of a subject or for improving digestibility of a raw material in a feed (e.g. nutrient digestibility, such as amino acid digestibility), or for improving nitrogen retention, or for avoiding the negative effects of necrotic enteritis or for improving feed conversion ratio (FCR) or for improving weight gain in a subject or for improving feed efficiency in a subject or for modulating (e.g. improving) the immune response of the subject, or for promoting the growth of beneficial bacteria in the gastrointestinal tract of a subject or for reducing populations of pathogenic bacteria in the gastrointestinal tract of a subject, or for reducing nutrient excretion in manure, which method comprising administering to a subject a direct fed microbial (DFM) in combination with a phytase derivable from Citrobacter spp.
Type:
Application
Filed:
January 19, 2012
Publication date:
December 12, 2013
Applicant:
DUPONT NUTRITION BIOSCIENCES APS
Inventors:
Luis Fernando Romero Millan, Luke Bernard, Peter Plumstead
Abstract: The present invention relates to the field of nutrition for children. In particular, the present invention relates to the nutritional compositions intended for children with an impaired function of the gastro-intestinal tract. One embodiment of the present invention relates to a nutritional composition to be administered to children with an impaired function of the gastrointestinal tract comprising probiotic micro-organisms. The probiotic micro-organisms may be non-replicating, for example bioactive heat treated probiotic micro-organisms.
Type:
Grant
Filed:
May 11, 2010
Date of Patent:
December 10, 2013
Assignee:
Nestec S.A.
Inventors:
Annick Mercenier, Sophie Nutten, Guenolee Prioult
Abstract: Invention is using M. brumae is a mycobacterium strain which stimulates immune system cells strongly, is non-pathogen for humans and has all of the defining attributes of the strain with catalog number 51384, American Type Culture Collection (ATCC) for therapy of superficial bladder cancers.
Abstract: Compositions and methods for protecting plants from fungal, bacterial, and viral diseases are provided, which compositions comprise at least one compound that produces systemic acquired resistance and at least one antifungal compound. Compositions of the disclosure may be applied directly to seeds, seedlings, shoots, roots, and/or foliage of the plant to be protected, thereby protecting them from the fungal, bacterial, and viral diseases.
Type:
Application
Filed:
August 9, 2011
Publication date:
December 5, 2013
Applicant:
Bayer Cropscience LP
Inventors:
Jennifer Riggs, Danise Beadle, Katharine Vuocolo
Abstract: The invention relates to a zinc-enriched biomass comprising living or subsequently killed micro-organisms, selected from the group consisting of Streptococcus thermophilus and Bifidobacterium animalis subsp. lactis and combinations thereof, a method for the manufacture of said zinc-enriched biomass, as well as food preparations, nutraceutic products, functional foods, cosmetic and cosmeceutic products, and food supplements, comprising the said biomass. Furthermore, new micro-organism strains are described which are able to concentrate zinc within the cell in very high amounts and therefore are particularly suitable for use in the method of the invention.
Abstract: The present invention provides methods for preventing biofilm formation on a surface. The present invention also relates to anti-biofilm forming agents, to methods of producing and using them, and to anti-fouling coatings produced therefrom.
Abstract: The present invention provides formulations and methods for preventing, suppressing, treating, or controlling pre- or post-harvest disease or decay in plants. In the inventive method, plants are contacted with a formulation including an antagonistic microorganism and a booster composition. The booster composition generally includes about 3 parts Kaolin clay, about 1 part yeast, about 1 part Yucca plant extract, and about 1 part calcium-source material. The antagonistic microorganism may be included in an amount of between about 0.02 parts and about 0.5 parts by weight of the formulation, with about 0.04 parts antagonistic microorganism being preferred in testing to date. The formulation is typically applied to the above ground structures of the plant, including its leaves, flowers, stems, trunk, blossoms and fruit.
Abstract: The invention encompasses phage ?mru including phage induction, phage particles, and the phage genome. Also encompassed are phage polypeptides, as well as polynucleotides which encode these polypeptides, expression vectors comprising these polynucleotides, and host cells comprising these vectors. The invention further encompasses compositions and methods for detecting, targeting, permeabilising, and inhibiting microbial cells, especially methanogen cells, using the disclosed phage, polypeptides, polynucleotides, expression vectors, or host cells.
Type:
Grant
Filed:
September 25, 2008
Date of Patent:
November 26, 2013
Assignee:
Pastoral Greenhouse Research Limited
Inventors:
Eric Heinz Altermann, Graeme Trevor Attwood, Sinead Christine Leahy, William John Kelly, Robert Starr Ronimus, Dong Li, Zhanhao Kong, Linley Rose Schofield, Debjit Dey, Catherine Mary Tootill, Carrie Sang, Christina Diane Moon, Petrus Hendricus Janssen
Abstract: Use of bacterial cells of the genus Tenacibaculum, from the crude cellular extract or from its cultivation supernatants, capable of degrading N-acyl homoserine lactones, for quorum quenching, for treatment of infectious bacterial illnesses or to inhibit formation of biofilms.
Type:
Grant
Filed:
July 23, 2009
Date of Patent:
November 19, 2013
Assignee:
Universidade de Santiago de Compostela
Inventors:
Ana Maria Otero Casal, Manuel Romero Bernárdez, Arturo Roca Rivada
Abstract: Signal peptides and polypeptides from Methanobrevibacter ruminantium, a methanogenic archaea present in ruminants. Methods of using these peptides to permeabilise microbial cells, particularly M. ruminantium strain M1? (DSM 1093).
Type:
Grant
Filed:
September 25, 2008
Date of Patent:
November 19, 2013
Assignee:
Pastoral Greenhouse Research Limited
Inventors:
Graeme Trevor Attwood, William John Kelly, Eric Heinz Altermann
Abstract: The object of the present invention is to provide a technique to inhibit methanogens from producing methane. The use of Alcaligenes faecalis can inhibit methanogens from producing methane.
Abstract: A novel Bacillus thuringiensis crystal protein exhibiting insect inhibitory activity is disclosed. Growth of Lygus insects is significantly inhibited by providing the novel crystal protein in Lygus insect diet. Polynucleotides encoding the crystal protein, transgenic plants and microorganisms that contain the polynucleotides, isolated peptides derived from the crystal protein, and antibodies directed against the crystal protein are also provided. Methods of using the crystal protein and polynucleotides encoding the crystal protein to control Hemipteran insects are also disclosed.
Type:
Application
Filed:
July 25, 2013
Publication date:
November 14, 2013
Applicant:
MONSANTO TECHNOLOGY LLC
Inventors:
James A. Baum, Stanislaw Flasinski, Gregory R. Heck, Stephen R. Penn, Uma Rao Sukuru, Xiaohong Shi
Abstract: The invention relates to the oral or nutraceutical cosmetic use of an effective amount of at least one monounsaturated fatty acid, a salt thereof and/or an ester thereof, as an active agent for treating and/or preventing skin complexion imperfections.
Abstract: Improved (safer and more effective) methods of therapy using TNF-R agonists, e.g., CD40 agonists are provided. These methods provide for the addition of an amount of a type 1 interferon and/or a TLR agonist that is effective to prevent or reduce the toxicity (liver toxicity) that may otherwise result in some patients of the TNF-R agonist is used as a monotherapy (without the type 1 interferon and/or TLR agonist).
Type:
Application
Filed:
April 16, 2013
Publication date:
November 14, 2013
Inventors:
Randolph J. Noelle, Ross M. Kedl, Cory L. Ahonen
Abstract: The present invention relates to an eco-friendly probiotic composition, and more particularly, to a probiotic composition for livestock production, comprising a lactic acid bacteria culture medium and an organic acid, wherein the organic acid is contained in an amount of 0.002 to 0.1 parts by weight relative to 1 parts by weight of the lactic acid bacteria culture medium. The present invention also relates to a method for preparing the composition. The eco-friendly probiotic composition of the present invention does not contain antibiotics and may exhibit complex effect of sterilization and virucidal effectiveness.
Type:
Application
Filed:
January 10, 2012
Publication date:
November 7, 2013
Applicants:
CTC BIO, INC., GWANGJU AGRICULTURAL TECHNOLOGY CENTER
Abstract: Dry stabilizing compositions for bioactive materials include sugars and hydrolyzed proteins, and may be formed into tablets or other forms providing enhanced stability for the bioactive material. Compositions containing the bioactive materials may be produced by a method that includes (a) combining the bioactive material with other ingredients in an aqueous solvent to form a viscous slurry; (b) snap-freezing the slurry in liquid nitrogen to form solid frozen particles, beads, droplets or strings; (c) primary drying by water removal under vacuum of the product of step (b) while maintaining it at a temperature above its freezing temperature; and (d) secondary drying of the product of step (c) at maximum vacuum and a temperature of 20° C. or higher for a time sufficient to reduce the water activity to below 0.3 Aw.
Type:
Application
Filed:
March 25, 2013
Publication date:
November 7, 2013
Inventors:
Moti Harel, Qiong Tang, Trisha Rice, Kimberly Jennings, Brian Carpenter, Roger Drewes, Elizabeth Raditsis, January Scarbrough
Abstract: Formulations are provided for detoxification support. The formulations generally include a trigger complex, an elemental complex and a coenzyme-vitamin B complex. The trigger complex is high in fiber such as glucomannan and includes Metallo-Lactoferrin protein in an alkaline buffer system. The elemental complex includes one or more trace element as a suitable salt. The coenzyme-vitamin B complex includes one or more coenzyme, coenzyme precursor and/or B-vitamin. The compositions may optionally include additional components such as Lactic Acid bacteria, L-theanine, cranberry root extract, tumeric root extract, inulin and blond psyllium. The compositions can be administered orally in a variety of forms.
Type:
Application
Filed:
July 1, 2013
Publication date:
November 7, 2013
Inventors:
A. Satyanarayan Naidu, A.G. Tezus Naidu, A.G. Sreus Naidu
Abstract: The invention relates to compositions for preparing a beverage, the compositions comprise a microorganism and/or an enzyme capable of hydrolysing chlorogenic acids of a coffee extract to phenolic acids. When a beverage prepared with the compositions of the invention is consumed chlorogenic acids present in coffee extract is hydrolysed to improve antioxidant and/or anti-inflammatory properties compared to a similar conventional beverage.
Type:
Application
Filed:
June 25, 2013
Publication date:
October 31, 2013
Inventors:
Rachid Bel-Rhlid, Karin Kraehenbuehi, Christophe Cavin, Thomas Wolfgang Raab, Nicolas Page
Abstract: The invention relates to virus-modified bacteria ghosts and the use thereof, for example, as carrier and targeting vehicles for active ingredients.
Abstract: Crude solid vanillin-containing material is precipitated from a solution obtained by biotransformation, and purified by a process comprising contacting it with a purification fluid selected from (a) a liquefied gas whose pressure exceeds its critical pressure and whose temperature is below its critical temperature; (b) a supercritical fluid; (c) a gas. The fluid is preferably liquid carbon dioxide. The temperature is maintained below 25° . The product may be further purified by treatment with CO2 in a fluid bed drier. The crude material is preferably one precipitated from a solution resulting from biotransformation of ferulic acid. A new strain of Amycolatopsis capable of generating high concentrations of vanillin with minimal odoriferous by-products (e.g. guaiacol) is also disclosed.
Type:
Grant
Filed:
July 14, 2011
Date of Patent:
October 22, 2013
Assignee:
SAF-ISIS
Inventors:
Steve Heald, Steve Myers, Tim Walford, Keith Robbins, Colin Hill
Abstract: The invention provides immunogenic compositions useful for inhibiting, treating, protecting, or preventing infection by Actinobacillus suis. These immunogenic compositions are demonstrated to usefully stimulate immunogenic responses in treated pigs. Some vaccines stimulated reactions sufficient to be protective against A. suis. In addition, the invention provides kits comprising the immunogenic compositions; as well as, methods of using the compositions and kits.
Type:
Grant
Filed:
November 9, 2010
Date of Patent:
October 22, 2013
Assignee:
Boehringer Ingelheim Vetmedica, Inc.
Inventors:
Jeremy Kroll, Philip Utley, Dianna Murphy Jordan
Abstract: The use of a probiotic Lactobacillus rhamnosus and a probiotic Bifidobacterium longumin the manufacture of a medicament or therapeutic nutritional composition for administration to an infant during at least the first three months of life for the long-term prophylaxis of diarrhea in infants and young children.
Abstract: Naturally occurring lecithins and/or oleic acid stimulate the growth and lactic acid producing activity of Lactobacillus and Bifidobacterium species of probiotic bacteria, and replace polysorbate 80 for those products. They can be used in naturally occurring form, or where they are to be combined with probiotics in a carrier, or they can be treated to yield a stable powdered form of these naturally oily compounds. They can be sold as combined prebiotic/probiotic formulations in the same carrier, or sold as separate dietary supplements, e.g., in capsule or tablet form, to be used with the probiotic formulation as desired.